The activation of the NFkB signaling pathway by the overexpression of Toll-like receptors (TLRs), both on microglia and neurons, leads to the release of cytokines and chemokines, thus resulting in the chronic inflammation observed in AD [86,87,88]. Here, NFKB1 is linked to Alzheimer disease.